MetLife, Inc.

MET Financial Insurance Life

MetLife, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $77.1 billion, up 8.59% from fiscal 2024. In the quarter to June 2026, revenue grew 10.5%, EPS grew 5.83%, free cash flow grew 1.87% and total debt fell 1.03%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, operating cash flow growth for five.

100.87 0.60 +0.60%
Market cap
$63.7B
P/E
19.3×
Fwd P/E
9.8×
Dividend yield
2.30%
F-score
7/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

Insider Decisions trades per month

Total sells 1.74
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — — — — — 1 — — — —
Insider Ownership 17.30%

Capital & Financial Ratios $m

Market Cap 63,720.00
Revenue 79,403.00
Net Income 3,403.00
Free Cash Flow 15,558.00
Net Debt 833.00
Current Ratio 0.15
Debt/Equity 0.73
P/E ratio 19.32
Fwd P/E 9.84
P/S ratio 0.82
P/B ratio 2.34
Past 5Y EPS Growth (3.68%) (below 0%: weak)
This Y EPS Growth 15.84% (at or above 15%: strong)
Next Y EPS Growth 9.03%
Next Y revenue growth 3.38%
Next 5Y EPS Growth 12.16%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

P/E against its own 10 years 83.69%
10-year low 10-year high
P/S against its own 10 years 77.33%
10-year low 10-year high
P/B against its own 10 years 99.41%
10-year low 10-year high

Dividends

Payout Ratio 0.44
Annual Dividend Rate 2.32
Annual Dividend Yield 2.30%
total individual payouts
2028 Powerpack
2027 Powerpack
2026 2.34
0.57
0.59
0.59
2025 2.25
0.55
0.57
0.57
0.57
2024 2.16
0.52
0.55
0.55
0.55
2023 2.06
0.50
0.52
0.52
0.52
2022 1.98
0.48
0.50
0.50
0.50
2021 1.90
0.46
0.48
0.48
0.48
2020 1.82
0.44
0.46
0.46
0.46
2019 1.74
0.42
0.44
0.44
0.44
2018 1.66
0.40
0.42
0.42
0.42
2017 1.47
0.36
0.36
0.36
0.40
2016 1.40
0.33
0.36
0.36
0.36
predictions special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 20,639 20,068 22,032 19,301
Receivables 29,161 30,056 49,719 51,061
Inventory — — — —
Other — — — —
49,800 50,124 71,751 70,362
2023 2024 2025 Q'26
Payables 219,707 215,511 231,687 229,293
ST’ Debt 3,280 3,629 4,510 5,604
Other 219,269 221,445 236,857 245,458
442,256 440,585 473,054 480,355

Compound Annual Growth %

10y 5y 3y
Sales 2.31% 2.59% 3.88%
Cash Flow 1.98% 7.99% 9.43%
Earnings (4.85%) (9.38%) (14.63%)
Book Value (8.33%) (17.45%) (1.63%)

Revenue $m

Mar Jun Sep Dec Year
’26 19,074 19,154 — — —
’25 18,569 17,340 17,361 23,814 77,084
’24 16,057 17,823 18,440 18,666 70,986
’23 15,388 16,623 15,866 19,028 66,905
’22 15,405 15,474 22,283 15,608 68,770
’21 15,562 18,524 16,905 17,705 68,696
’20 18,310 14,099 16,015 19,418 67,842
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 2,687 2,228 — — —
’25 4,262 2,187 3,567 7,076 17,092
’24 2,328 3,490 4,169 4,611 14,598
’23 2,026 3,038 3,475 5,182 13,721
’22 2,040 4,393 4,310 2,301 13,044
’21 1,496 2,254 3,506 5,091 12,347
’20 1,847 846 3,793 5,153 11,639
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 2,687 2,228 — — —
’25 4,262 2,187 3,567 7,076 17,092
’24 2,328 3,490 4,169 4,611 14,598
’23 2,026 3,038 3,475 5,182 13,721
’22 2,040 4,393 4,310 2,301 13,044
’21 1,496 2,254 3,506 5,091 12,347
’20 1,847 846 3,793 5,153 11,639
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 1.74 1.09 — — —
’25 1.28 1.03 1.22 1.17 4.71
’24 1.10 1.28 1.81 1.78 5.94
’23 0.02 0.48 0.56 0.77 1.81
’22 1.97 1.12 1.46 1.66 6.55
’21 0.33 3.83 1.77 1.39 7.31
’20 4.75 0.07 0.69 0.14 5.68
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1.8
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 31.19 44.18 37.76 40.25 22.85 45.73 57.41 48.95 64.61 65.21

Analyst estimates 2026–2028

Powerpack
High 51.77 55.91 55.21 51.60 53.28 67.68 77.36 73.92 89.05 88.09
People
People Employees 58,000 49,000 48,000 49,000 46,500 43,000 45,000 45,000 45,000 46,000
Revenue/emp, $m 1.05 1.27 1.42 1.42 1.46 1.60 1.53 1.49 1.58 1.68
Income, $m
Income, $m Revenue 60,787 62,308 67,941 69,620 67,842 68,696 68,770 66,905 70,986 77,084
Gross margin, % 29.66 27.54 29.47 29.42 29.59 29.64 26.66 22.16 25.97 23.83
EBT 4,281 3,536 6,307 6,795 6,927 8,518 6,364 2,162 5,622 4,661
EBT margin, % 7.04 5.68 9.28 9.76 10.21 12.40 9.25 3.23 7.92 6.05
Net income 854 4,020 5,128 5,909 5,418 6,876 5,302 1,602 4,444 3,403
Depreciation (458) (249) (385) (369) (197) (180) (319) (614) (798) (1,087)
Per share, $
Per share, $ Revenue 55.24 58.25 67.54 74.25 74.73 79.63 85.62 88.30 100.49 115.24
Earnings 0.63 3.38 4.91 6.06 5.68 7.31 6.60 1.81 5.94 4.71
Cash flow 13.42 11.48 11.67 14.70 12.82 14.31 16.24 18.11 20.67 25.55
Capex 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Free cash flow 13.42 11.48 11.67 14.70 12.82 14.31 16.24 18.11 20.67 25.55
Book value 61.52 55.03 52.65 70.80 82.42 78.53 37.51 39.93 39.22 42.88
Shares, m 1,101 1,070 1,006 938 908 863 803 758 706 669
Valuation, ×
Valuation, × P/E 79.31 14.72 8.29 8.41 8.31 8.54 11.55 36.80 13.72 16.80
P/S 0.88 0.86 0.61 0.69 0.63 0.78 0.84 0.76 0.81 0.69
P/B 0.79 0.91 0.78 0.72 0.57 0.80 1.92 1.69 2.09 1.84
EV/Sales 1.02 0.99 0.63 0.70 0.62 0.76 0.82 0.75 0.80 0.65
EV/FCF 4.18 5.00 3.65 3.56 3.59 4.22 4.33 3.63 3.90 2.93
Cash, $m
Cash, $m Operating cash flow 14,774 12,283 11,738 13,786 11,639 12,347 13,044 13,721 14,598 17,092
Capex — — — — — — — — — —
Free cash flow 14,774 12,283 11,738 13,786 11,639 12,347 13,044 13,721 14,598 17,092
Balance, $m
Balance, $m Working capital (330,446) (351,307) (356,057) (373,752) (398,370) (389,222) (386,125) (392,456) (390,461) (401,303)
Total debt 21,126 20,428 17,304 17,844 18,994 18,196 18,696 19,465 19,191 19,329
Net debt 8,475 7,727 1,483 1,246 (801) (1,851) (1,499) (1,174) (877) (2,703)
Shareholders’ equity 67,702 58,870 52,958 66,382 74,817 67,749 30,125 30,253 27,703 28,680
Returns, %
Returns, % ROA 0.08 0.48 0.71 0.80 0.68 0.86 0.72 0.20 0.62 0.45
ROIC 3.51 3.32 7.24 6.28 5.85 8.08 13.89 4.65 13.10 11.21
ROE 1.10 6.17 8.91 9.59 7.35 9.33 10.42 4.57 14.58 11.26
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

MetLife, Inc. vs peers in Insurance Life (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
MET MetLife, Inc. $63.7B 19.3× 9.8× +10.46% (above 0%: growing) +5.83% (above 0%: growing) +1.87% (above 0%: growing) 25.57% 5.40%
AFL Aflac Incorporated $59.2B 12.8× 16.3× −1.03% (below 0%: shrinking) +46.43% (above 0%: growing) −71.93% (below 0%: shrinking) 49.21% 25.72% Compare
PRU Prudential Financial, Inc. $40.1B 10.4× 9.3× +14.10% (above 0%: growing) +88.59% (above 0%: growing) +101.89% (above 0%: growing) 34.85% 7.52% Compare
PUK Prudential Public Limited Company $29.5B 16.7× — −52.23% (below 0%: shrinking) +122.99% (above 0%: growing) −99.72% (below 0%: shrinking) 0.00% 0.00% Compare
UNM Unum Group $14.6B 21.5× 11.8× +0.26% (above 0%: growing) −16.58% (below 0%: shrinking) +48.17% (above 0%: growing) 35.37% 11.36% Compare
GL Globe Life Inc. $12.9B 11.0× 10.3× +8.00% (above 0%: growing) +20.06% (above 0%: growing) +0.88% (above 0%: growing) 39.24% 24.44% Compare
JXN Jackson Financial Inc. $8.9B 176× 13.1× +135.67% (above 0%: growing) +292.31% (above 0%: growing) +57.63% (above 0%: growing) (630.95%) 411.90% Compare
PRI Primerica, Inc. $8.7B 11.3× 10.9× +9.04% (above 0%: growing) +19.41% (above 0%: growing) +5.06% (above 0%: growing) 82.88% 30.52% Compare
LNC Lincoln National Corporation $7.7B 3.4× 7.0× +12.31% (above 0%: growing) +76.55% (above 0%: growing) −155.08% (below 0%: shrinking) 37.98% 37.98% Compare
Median of peers $13.8B 12.1× 10.9× +8.52% +61.49% +2.97% 36.68% 25.08%

All 17 Insurance Life stocks →

MET metrics, ten years each

MetLife, Inc. (MET) key facts

  • Strength: MetLife, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $77.1 billion, up 8.59% from fiscal 2024.
  • MetLife, Inc. (MET) is an Insurance Life company in the Financial sector, listed on the New York Stock Exchange.
  • As of October 16, 2026, MET traded at $100.87, a market capitalization of $63.7 billion.
  • MetLife, Inc. pays an annual dividend of $2.32 per share, a yield of 2.30%, with a payout ratio of 44.4%.
  • Return on equity was 11.3% and debt-to-equity 0.73.
  • Its Piotroski F-score is 7 out of 9 for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

MetLife, Inc. (MET) Latest News

14 Aug

13 Aug

Impact 4 · transcript

8 Aug

6 Aug

Impact 4 · transcript

1 Jun

Impact 3 · transcript

11 May

stockrow.com/MET · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com